Zinc Gluconate
The most common zinc salt in cold lozenges. It shortens colds when the total daily zinc dose is high enough and treatment starts early, though the trial record is inconsistent and the lozenges taste unpleasant.
Evidence last reviewed: August 2026
What the science says
- Shorter colds at adequate zinc doses Moderate evidence
A meta-analysis comparing zinc acetate and zinc gluconate lozenges found that both salts shortened colds when total daily zinc was around 80–90 mg, with no significant difference between the two salts. Low-dose gluconate lozenges did not show a benefit, which explains much of the inconsistency in older trials.
- Earlier meta-analyses were mixed Moderate evidence
A 1997 meta-analysis of zinc salt lozenges found the evidence conflicting and dose-dependent. A 2013 Cochrane review reported reduced cold duration but was later withdrawn over methodological concerns, so it should not be cited as current support.
- Prevention is not established Limited evidence
The trials tested lozenges started within about a day of symptom onset as treatment. Taking zinc gluconate continuously to avoid catching colds has much weaker support and carries the risk of copper depletion.
Dosage & safety
Scientific references
Where to buy
Ships to 180+ countries · welcome discount for new customers
Referral link — this site may earn a commission on purchases.
Related in Immunity
- Vitamin C Limited evidence
- Zinc Moderate evidence
- Elderberry Limited evidence
- L-Lysine Limited evidence
- Echinacea Limited evidence
- Andrographis Moderate evidence